← Every company
Oramed Pharmaceuticals Inc SEC Filings
What Oramed Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ORMP overview →Filings on file
104
since Nov 25, 2016
Warning signs
1
latest May 15, 2026
Last results
Nov 17, 2025
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 15, 2026 | Late filing notice NT 10-Q | Read ↗ |
Source: Oramed Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ORMP
Company overviewEverything on ORMP in one place, with the price.Insider tradingWhat ORMP's own officers and directors buy and sell.Executive payWhat ORMP awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ORMP.Funds holding itWhich funds and ETFs hold ORMP, and how big a bet.PatentsWhat ORMP is filing at the patent office.